期刊论文详细信息
BMC Veterinary Research
A controlled study to determine the efficacy of Loxostylis alata (Anacardiaceae) in the treatment of aspergillus in a chicken (Gallus domesticus) model in comparison to ketoconazole
Vinny Naidoo1  Jacobus N Eloff2  Neil Duncan3  Mohammed M Suleiman4 
[1] Section of Pharmacology and Toxicology, Department of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria, Pretoria, South Africa;Phytomedicine Programme, Department of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria, Pretoria, South Africa;Section of Pathology, Department of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria, Pretoria, South Africa;Department of Physiology and Pharmacology, Faculty of Veterinary Medicine, Ahmadu Bello University, Zaria, Nigeria
关键词: Broiler chicks;    Aspergillosis;    Loxostylis alata;   
Others  :  1119677
DOI  :  10.1186/1746-6148-8-210
 received in 2012-07-11, accepted in 2012-10-29,  发布年份 2012
PDF
【 摘 要 】

Background

The poultry industry due to intensive methods of farming is burdened with losses from numerous infectious agents, of which one is the fungus Aspergillus fumigatus. In a preliminary study, the extracts of Loxostylis alata A. Spreng, ex Rchb. showed good activity in vitro against A. fumigatus with a minimum inhibitory concentration of 0.07 mg/ml. For this study crude, a crude acetone extract of L. alata leaves was evaluated for its acute toxicity in a healthy chicken model and for efficacy in an infectious model of aspergillosis (A. fumigatus).

Results

At a dose of 300 mg/kg, the extract induced some toxicity characterised by decreased feed intake and weight loss. Consequently, 100 and 200 mg/kg were used to ascertain efficacy in the infectious model. The plant extract significantly reduced clinical disease in comparison to the control in a dose dependant manner. The extract was as effective as the positive control ketoconazole dosed at 60 mg/kg.

Conclusions

The results indicate that a crude extract of L. alata leaves has potential as an antifungal agent to protect poultry against avian aspergillosis.

【 授权许可】

   
2012 Suleiman et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150208100127348.pdf 3672KB PDF download
Figure 7. 84KB Image download
Figure 6. 23KB Image download
Figure 5. 26KB Image download
Figure 4. 94KB Image download
Figure 3. 80KB Image download
Figure 2. 94KB Image download
Figure 1. 33KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】
  • [1]Morris MP, Fletcher OJ: Disease prevalence in Georgia turkey flocks in 1986. Avian Dis 1988, 32:404-406.
  • [2]Richard JL, Thurston JR: Rapid haematogenous dissemination of Aspergillus fumigatus and A. flavus spores in turkey poults following aerosol exposure. Avian Dis 1983, 27:1025-1033.
  • [3]Kunkle RA: Fungal infections. In Diseases of Poultry. 11th edition. Edited by Saif YM, Barnes HJ, Glisson JR, Fadly J, Mcdonald LR, Swayne DE. Iowa: Iowa State University Press; 2003:883-895.
  • [4]Tell LA: Aspergillosis in mammals and birds: impact on veterinary medicine. Med Mycol 2005, 43:71-73.
  • [5]Singh H, Grewal GS, Singh N: Mycotic salpingitis in a Japanese quail (Coturnix coturnix japonica ). Avian Dis 1994, 38:910-913.
  • [6]Perelman B, Kuttin ES: Aspergillosis in ostriches. Avian Path 1992, 21:159-163.
  • [7]Richard JL: Aspergillosis. In Diseases of Poultry. Edited by Calnek BW. London: Mosby-Wolfe; 1997:351-365.
  • [8]Fitzgerald SD, Moisan PG: Mycotic rhinitis in an ostrich. Avian Dis 1995, 39:194-196.
  • [9]Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA: Pulmonary aspergillosis in the acquired immunodeficiency syndrome. New Engl J Med 1991, 324:654-662.
  • [10]Uno J, Shigematsu ML, Arai T: Primary site of action of ketoconazole on Candida albicans. Antimicrob Agents Ch 1982, 21:912-918.
  • [11]Lyman CA, Walsh TJ: Systematically administered antifungal agents. a review of their clinical pharmacology and therapeutic applications. Drugs 1992, 44:9-35.
  • [12]Orosz SE: Overview of aspergillosis: pathogenesis and treatment options. Semin Avian Exotic Pet 2000, 9:59-65.
  • [13]Di Domenico B: Novel antifungal drugs. Curr Opin Microbiol 1998, 2:509-515.
  • [14]Ablordeppey S, Fan P, Ablordeppey JH, Mardenborough L: Systemic antifungal agents against AIDS-related opportunistic infections: current status and emerging drugs in development. Curr Med Chem 1999, 6:1151-1195.
  • [15]Coates-Palgrave M: Keith Coates-Palgrave Trees of Southern Africa. 3rd edition. Cape Town: Struik Publishers; 2002:1212.
  • [16]Suleiman MM, McGaw LJ, Naidoo V, Eloff JN: Evaluation of several tree species for activity against the animal fungal pathogen Aspergillus fumigatus. S Afr J Bot 2009, 76:64-71.
  • [17]Suleiman MM, McGaw LJ, Naidoo V, Eloff JN: Detection of antimicrobial compounds by bioautography of different extracts of leaves of selected South African tree species. Afr J Tradit Complem 2010, 7:64-78.
  • [18]North MO: Commercial chicken production manual. 2nd edition. Connecticut: AVI Publishing Company; 1981.
  • [19]Femenia F, Fontaine JJ, Lair-Fulleringer S, Berkova N, Huet D, Towanou N, Rakotovao F, Granet OI, Loćh GL, Arné P, Guillot J: Clinical, mycological and pathological findings in turkeys experimentally infected by Aspergillus fumigatus. Avian Path 2007, 36:213-219.
  • [20]De Hoog GS, Gene J, Figueras MJ: Atlas of Clinical Fungi. 2nd edition. Utrecht: Centraalbureau voor Schimmelcultures; 2000.
  • [21]Pollock C, Carpenter JW, Antinoff N: Antifungal agents used in birds. In Exotic Animal Formulary. 3rd edition. Edited by Carpenter JW. Missouri: Elsevier Saunders; 2005:165-174.
  • [22]Bancroft JD, Gamble M: Theory and practice of histological techniques. 5th edition. Livingstone: Church Hill; 2003.
  • [23]Delap SK, Skeeles JK, Beasley JN, Kreider DL, Whitfill CE, Houghten GE, Walker EM Jr, Cannon DJ, Earls PL: In vivo studies with dimethyldithiocarbamate, a possible new antimicrobial for use against Aspergillus fumigatus in poultry. Avian Dis 1989, 33:497-501.
  • [24]Kassie F, Parzefall W, Musk S, Johnson I, Lamprecht G, Sontag G, Knasmueller S: Genotoxic effects of crude juices from Brassica vegetables and juices and extracts from phytopharmaceutical preparations and spices of cruciferous plants origin in bacterial and mammalian cells. Chem Biol Interact 1996, 102:1-16.
  • [25]De Sã Ferrira ICF, Ferrão Vargas VM: Mutagenicity of medicinal plant extracts in salmonella/microsome assay. Phytother Res 1999, 13:397-400.
  • [26]Rang HP, Dale MM, Ritter JM, Moore PK: Pharmacology, 5’th edition. Livingstone: Churchill; 2003.
  • [27]Lorke D: A new approach to practical acute toxicity testing. Arch Toxicol 1983, 54:275-287.
  • [28]Organisation for Economic Cooperation and Development (OECD): Guidance Document on the Recognition, Assessment and Use of Clinical Signs as Humane Endpoints for Experimental Animals Used in Safety Evaluation Environmental Health and Safety Monograph Series on Testing and Assessment No 19. 2000. http://www.oecd.org/env/health webcite
  • [29]Naidoo V, McGaw LJ, Bisschop SPR, Duncan N, Eloff JN: The value of plant extracts with antioxidant activity in attenuating coccidiosis in broiler chickens. Vet Par 2008, 153:214-219.
  • [30]South African Poultry Association (SAPA): Annual report 2008. [http://www.SApoultry.co.za webcite]
  • [31]Akan M, Hazıroğlu R, Lhan Z, Sareyyüpoğlu B, Tunca R: A case of aspergillosis in a broiler breeder flock. Avian Dis 2002, 46:497-501.
  • [32]Julian RJ, Goryo M: Pulmonary aspergillosis causing right ventricular failure and ascites in meat type chickens. Avian Path 1990, 19:643-654.
  • [33]Lukas G, Brindle SG, Greengard P: The route of absorption of intraperitoneally administered compounds. J Pharmacol Exp Ther 1971, 178:562-566.
  • [34]Mueller RA, Shideman FE: A comparison of the absorption, distribution and metabolism of reserpine in infant and adult rats. J Pharmacol Exp Ther 1968, 163:91-97.
  • [35]Horita A: The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition. Toxicol Appl Pharm 1961, 3:474-480.
  文献评价指标  
  下载次数:148次 浏览次数:0次